Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CRLS1 antibody

The Rabbit Polyclonal anti-CRLS1 antibody has been validated for WB, IHC and ELISA. It is suitable to detect CRLS1 in samples from Human and Mouse.
Catalog No. ABIN7112324

Quick Overview for CRLS1 antibody (ABIN7112324)

Target

See all CRLS1 (CLS) Antibodies
CRLS1 (CLS) (Cardiolipin Synthase (CLS))

Reactivity

  • 16
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human, Mouse

Host

  • 15
  • 1
Rabbit

Clonality

  • 16
Polyclonal

Conjugate

  • 11
  • 1
  • 1
  • 1
  • 1
  • 1
This CRLS1 antibody is un-conjugated

Application

  • 14
  • 13
  • 10
  • 3
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA
  • Purification

    Immunogen affinity purified

    Purity

    ≥95 % as determined by SDS-PAGE

    Immunogen

    cardiolipin synthase 1

    Isotype

    IgG
  • Application Notes

    WB: 1:500-1:2000, IHC: 1:20-1:200

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    -20°C for 12 months (Avoid repeated freeze / thaw cycles.)

    Expiry Date

    12 months
  • Target

    CRLS1 (CLS) (Cardiolipin Synthase (CLS))

    Alternative Name

    CRLS1

    Background

    Synonyms:C20orf155, CLS1 Background:Catalyzes the synthesis of cardiolipin(CL)(diphosphatidylglycerol) by specifically transferring a phosphatidyl group from CDP-diacylglycerol to phosphatidylglycerol(PG). CL is a key phospholipid in mitochondrial membranes and plays important roles in maintaining the functional integrity and dynamics of mitochondria under both optimal and stress conditions.

    Molecular Weight

    50 kDa

    Gene ID

    54675

    UniProt

    Q9UJA2
You are here:
Chat with us!